Back

Graph-based modeling of multiparametric MRI deciphers molecular states of high-grade glioma invasion with prognostic implications

Flick, M. J.; Kenaston, M.; Sarkar, S.; LaFond, G. M.; Hart, I.; Mazza, G.; Cramer, J.; Bendok, B. R.; Turkmani, A.; Krishna, C.; Zimmerman, R.; Parker, J.; Li, J.; Donev, K.; Bhat, K.; Baxter, L. C.; Zhou, Y.; Quarles, C. C.; Craig, D.; Iavarone, A.; Ensign, S. F.; Ceccarelli, M.; Kannan, K.; Tran, N. L.; Hu, L. S.

2026-07-08 cancer biology
10.64898/2026.06.18.733053 bioRxiv
Show abstract

AbstractThe infiltrative, non-enhancing margin of IDH wildtype high grade glioma (IDHwt HGG) harbors distinct molecular programs that drive invasion and therapeutic resistance, yet remains largely unevaluable by conventional tissue sampling approaches and by conventional imaging. Here we show that this invasive architecture is encoded within multiparametric MRI (mpMRI) feature relationships and can be decoded using a graph-based framework trained on multiregional image-localized biopsies. Across 134 spatially matched biopsy-imaging pairs from 35 patients with primary IDHwt HGG (29 glioblastomas (GBM) and 6 non-glioblastoma HGGs), unsupervised graph community detection identifies two imaging-defined clusters that localize to invasive tumor regions without molecular supervision. Transcriptomic profiling associates these clusters with neuronal (NEU) and glycolytic-plurimetabolic (GPM) molecular programs. Building on this framework, a graph convolutional network (GCN) accurately predicts NEU and GPM transcriptional states in independent training and validation cohorts and significantly outperforms conventional convolutional neural networks. Applied to whole-tumor mpMRI volumes, the trained GCN generates spatially resolved probability maps that quantify the distribution and relative burden of NEU and GPM programs across both MRI contrast-enhancing and non-enhancing invasive regions. These imaging-derived molecular maps stratify patients by overall survival. Increased GPM burden is associated with poorer survival, consistent with the aggressive behavior associated with mesenchymal-like transcriptional programs in IDHwt HGG. In contrast, increased NEU burden is associated with improved survival, identifying a previously unrecognized imaging-derived prognostic biomarker that was not detected by biopsy-based molecular classification alone. Together, these findings establish a graph-based imaging framework for spatially resolved molecular classification of invasive IDHwt HGG and demonstrate that whole-tumor molecular state architecture carries prognostic information beyond conventional tissue sampling.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 12%
14.9%
2
Neuro-Oncology Advances
25 papers in training set
Top 0.1%
5.5%
3
Clinical Cancer Research
64 papers in training set
Top 0.3%
5.4%
4
Cell Reports
1498 papers in training set
Top 9%
4.3%
5
Cancer Cell
42 papers in training set
Top 0.3%
4.0%
6
npj Precision Oncology
53 papers in training set
Top 0.3%
4.0%
7
Neuro-Oncology
36 papers in training set
Top 0.2%
3.4%
8
Cancer Research
130 papers in training set
Top 1%
3.2%
9
Advanced Science
286 papers in training set
Top 2%
3.2%
10
Journal of Neuro-Oncology
10 papers in training set
Top 0.1%
3.2%
50% of probability mass above
11
Scientific Reports
3612 papers in training set
Top 35%
3.2%
12
Cell Reports Medicine
153 papers in training set
Top 1%
3.1%
13
npj Imaging
12 papers in training set
Top 0.1%
2.4%
14
Genome Medicine
183 papers in training set
Top 2%
2.4%
15
Communications Medicine
113 papers in training set
Top 2%
2.1%
16
PLOS Computational Biology
1863 papers in training set
Top 13%
2.1%
17
eLife
5828 papers in training set
Top 46%
1.9%
18
Science Advances
1243 papers in training set
Top 18%
1.9%
19
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 26%
1.9%
20
Acta Neuropathologica Communications
89 papers in training set
Top 1%
1.7%
21
Nature Cancer
39 papers in training set
Top 0.8%
1.7%
22
PLOS ONE
5266 papers in training set
Top 50%
1.7%
23
Cancer Discovery
66 papers in training set
Top 1%
1.5%
24
Genome Biology
637 papers in training set
Top 6%
1.5%
25
Brain
168 papers in training set
Top 2%
1.1%
26
npj Digital Medicine
118 papers in training set
Top 3%
1.1%
27
Communications Biology
993 papers in training set
Top 22%
1.1%
28
Nature
645 papers in training set
Top 9%
1.0%
29
Nature Methods
385 papers in training set
Top 6%
1.0%
30
Science Translational Medicine
127 papers in training set
Top 3%
0.9%